Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Harari

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?P M Harari
Endocrine-Related Cancer|December 23, 2004
Epidermal growth factor receptor inhibition strategies in oncologyP M Harari
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2005
Promising new advances in head and neck radiotherapyP M Harari
Seminars in Radiation Oncology|October 26, 2001
Radiation response modification following molecular inhibition of epidermal growth factor receptor signalingP M Harari, S M Huang
Investigational New Drugs|February 9, 2000
Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical resultsS M Huang, P M Harari
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesisS M Huang, P M Harari
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiationP M Harari, S M Huang
Current Opinion in Oncology|May 1, 1995
Advances in radiation therapy for head and neck cancerP M Harari, T J Kinsella
Head & Neck|March 1, 1994
Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapyJ N Sarkaria, P M Harari
Cancer Research|April 23, 1999
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neckS M Huang, J M Bock, P M Harari
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?P M Harari
Endocrine-Related Cancer|December 23, 2004
Epidermal growth factor receptor inhibition strategies in oncologyP M Harari
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2005
Promising new advances in head and neck radiotherapyP M Harari
Seminars in Radiation Oncology|October 26, 2001
Radiation response modification following molecular inhibition of epidermal growth factor receptor signalingP M Harari, S M Huang
Investigational New Drugs|February 9, 2000
Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical resultsS M Huang, P M Harari
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesisS M Huang, P M Harari
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiationP M Harari, S M Huang
Current Opinion in Oncology|May 1, 1995
Advances in radiation therapy for head and neck cancerP M Harari, T J Kinsella
Head & Neck|March 1, 1994
Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapyJ N Sarkaria, P M Harari
Cancer Research|April 23, 1999
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neckS M Huang, J M Bock, P M Harari
Pageof 4